دوره 5، شماره 1 - ( 11-1395 )                   جلد 5 شماره 1 صفحات 6-16 | برگشت به فهرست نسخه ها


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karkhane M, Marzban A, Lashgarian H E, Zali M R. HCV medication affected by Genetic Variations in Host factors. Res Mol Med (RMM). 2017; 5 (1) :6-16
URL: http://rmm.mazums.ac.ir/article-1-227-fa.html
HCV medication affected by Genetic Variations in Host factors. Research in Molecular Medicine. 1395; 5 (1) :6-16

URL: http://rmm.mazums.ac.ir/article-1-227-fa.html


چکیده:   (633 مشاهده)

Although standard treatments are nearly life-saving in hepatitis C patients, all patients equally don’t respond to such medications. To achieve a favorable therapeutic response in all patients, medications might alter between individuals based on genetic factor variations. Hence, having a detailed knowledge of the affecting factors on the disease promotion could help us to organize an appropriate regime to treat the HCV patients. The data was collected from the clinical and molecular studies published during the last 15 years that elicited from electronic databases such as Pubmed, Google scholar, Medline, Scopus and web of sciences. The literature reviews the recent clinical studies with the genetic-based aspects, especially those factors affecting on the etiopathological and histological feature of hepatitis C, diagnostic, genetic and viral affecting criteria as well as some effective treatment strategies.

متن کامل [PDF 481 kb]   (114 دریافت)    
نوع مطالعه: review | موضوع مقاله: ويروس شناسي پزشکي
دریافت: ۱۳۹۶/۱/۲۲ | پذیرش: ۱۳۹۶/۳/۱۶ | انتشار: ۱۳۹۶/۳/۱۶

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
کد امنیتی را در کادر بنویسید

کلیه حقوق این وب سایت متعلق به Research in Molecular Medicine می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2015 All Rights Reserved | Research in Molecular Medicine

Designed & Developed by : Yektaweb